Open Nav

David Klein

Executive Chairman, President & CEO

Click Therapeutics, Inc.

David Benshoof Klein is a healthcare investor and entrepreneur with over 17 years life

science industry experience; he has played key roles in founding, financing and operating more

than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics which

develops and commercializes software as medical treatments: Digital Therapeutics™.

Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is

available nationwide through a wide variety of payers, providers, and employers. Click’s lead

prescription program is entering into a multi-center, randomized, controlled, parallel-group,

phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. He

formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and

strategic advisor to numerous publicly traded and privately held life science companies. Mr.

Klein holds a B.A. from Brandeis University and has been a guest lecturer at Columbia

University’s Biotechnology Program. A native New Yorker, Mr. Klein is an avid art enthusiast

and is co-founder and owner of Klein Sun Gallery, America’s leading Chinese contemporary

art gallery with locations in New York’s Chelsea art district and Beijing, China.

This speaker's sessions: